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Abstract 
Objectives: Examine impact of NHS funded private provision on NHS provision, access 
and inequalities. 
Design: Ecological study using routinely collected NHS inpatient data.  
Participants: All individuals undergoing a NHS funded elective hip arthroplasty in 
England from 2003/04 to 2012/13.  
Main outcome measures: Annual crude and standardised rates of hip arthroplasties 
per 100,000 population performed by NHS and private providers between 2004/05 and 
2012/13. 
Results: Age standardised rates of hip arthroplasty increased from 116.4 (95% CI 115.4 
to 117.4) to 148.7 (147.6 to 149.8) per 100,000 between 2004/05 to 2012/13. Provision 
shifted from NHS providers to private providers from 2007/08; NHS provision 
decreased 8.6% and private provision increased 188% between 2007/08 and 2012/13. 
There is evidence of risk selection; private sector hip arthroplasties on NHS patients 
from the most affluent areas increased 228% from 10.8 (10.2 to 11.5) to 35.4 (34.3-
36.5) per 100,000 compared to an increase of 186% from 8.8 (8.1-9.4) to 25.2 (24.1-
26.4) per 100,000 among patients from the least affluent areas between 2007/08 to 
2012/13. There was no statistically significant (p>0.05) widening in any measure of 
inequality (absolute, relative difference and slope and relative slope of index inequality) 
in hip arthroplasty rates between 2004/05 to 2012/13. 
Conclusion: Private provision substituted for NHS provision and did not add to overall 
provision favouring patients living in the most affluent area. Continuing the trend 
towards private provision and reducing NHS provision is likely to result in risk selection 
and widening inequalities in provision of elective hip arthroplasty in England. 
 
 
 
 
Key messages  
 
What is already known? 
 
Private sector provision of NHS funded care is increasing. 
 
Inequalities in elective hip arthroplasty exist by age, gender and deprivation.  
 
What this study adds? 
 
Rates of privately performed NHS funded elective hip arthroplasties are increasing and 
are substituting the decreased NHS provision. 
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Increasing private provision favours patients from the most affluent areas and may lead 
to widening inequalities. 
 
 
 
Introduction 
 
The 2012 Health and Social Care Act places duties on NHS England and Clinical 
Commissioning Groups (CCGs) to ‘have regard to the need to reduce inequalities 
between patients with respect to their ability to access health services’.(1)  
Following the NHS Plan in 2000, private providers of health care services have 
expanded rapidly.  In 2003, privately owned independent sector treatment centres 
(ISTCs) were commissioned to treat NHS patients, focussing on high–volume elective 
surgical procedures, despite concerns about cost, quality, and the ‘cherry picking’ of 
healthier patients over those with more complex health problems.(2-5) The ‘free choice’ 
agenda,(6) allowed any private provider of healthcare to provide elective care to any 
NHS patient provided they had registered with the relevant body.(7) Commercial 
tendering of NHS services is now virtually compulsory.(8) Between April 2013 and 
August 2014 a third of contracts to provide NHS clinical services were awarded to the 
private sector and between 2015 to 2016, NHS England expenditure on private sector 
provision of secondary care services reached £8.7 billion, representing 7.7% of total 
NHS expenditure in 2015/16.(9, 10)  
Elective hip arthroplasty is a common elective procedure with demonstrable 
improvements in quality of life. (11-13) In 2017 over a third of NHS funded elective hip 
arthroplasties were performed by the private sector.(14) Variations in elective hip 
arthroplasty rates are well documented; with female and older patients and those living 
in the most deprived areas less likely to receive treatment relative to need. (15-17) 
Early studies into the impact of commercial contracting and ISTCs suggested no impact 
on equity,(18) although a Scottish study found private provision of NHS funded elective 
hip arthroplasties was associated with reduced NHS provision and increased age and 
socio-economic inequalities in treatment rates. (19)  
 
Method 
 
All episodes of NHS funded elective and emergency primary hip arthroplasty (including 
hip resurfacing and hybrid hip replacements) by NHS or private provider performed in 
England from 01 April 1997 to 31 March 2013 were extracted from Hospital Episode 
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Statistics (HES) using OPCS4 procedure codes as defined by the Scottish Arthroplasty 
Project. (20) 
 
Patient level variables included age at time of admission, gender and area-level socio-
economic deprivation (Index of multiple deprivation, IMD) were obtained for each 
patient based on the 2001 lower layer super output area (LSOA) of residence. The IMD 
score was transformed into population quintiles with IMD 1 representing the 20% of 
patients living in the most deprived areas and IMD 5 representing the 20% of patients 
living in the least deprived areas in the population.  
 
Statistical analysis 
 
Numbers of elective and emergency hip arthroplasties and crude and age standardised 
rates per 100,000 population with 95% confidence intervals were calculated for each 
financial year from 1997/98 to 2012/13; standardisation was to the 2013 European 
population. Population denominators for England by financial year were obtained from 
mid-year ONS estimates corresponding to each financial year. Numbers of elective NHS 
provided and private provided hip arthroplasties and crude and age standardised rates 
per 100,000 population were calculated for each financial year from 2003/04 to 
2012/13. Crude and standardised rates were calculated by IMD quintile for each 
provider type and for all providers from 2004/05 to 2012/13. 
 
Measures of inequality 
Absolute and relative differences in age-standardised hip arthroplasties rates between 
the 20% least deprived and the 20% most deprived population for each year of data 
from 2004/05 onwards were calculated. We examined trends in absolute and relative 
differences over time by performing simple linear regression, using least squares 
methods.  
We calculated slope of index inequality (SII) and relative slope of index inequality (RII) 
for each year from 2004/05 onwards to measure the difference in age-standardised 
rates by taking into account the inequality across all adjacent quintiles of relative 
deprivation, rather than focusing only on the extremes, using previously developed 
techniques.(21, 22)  
For each year, the age-standardised rates for each IMD quintile were ranked and 
weighted according to the distribution in the population. The slope index of inequality 
(SII) is the linear regression coefficient that shows the relation between the age-
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standardised rates in each IMD quintile and the cumulative fraction of population 
ranked by deprivation. The SII can be interpreted as the absolute effect on treatment 
rates of moving from the lowest socioeconomic level through to the highest and has the 
advantage over more simple measures of inequalities by making use of all the data.(23) 
As SII is sensitive to the mean arthroplasty rate of the population, we also calculate the 
relative index of inequality by dividing the SII by the mean rate in the population. We 
examined trends in SII and RII over time by performing simple linear regression. 
 
All analysis was performed using Stata version 14 and Microsoft excel. All significance 
testing is to p<0.05. 
 
Patient and Public Involvement 
No patients or public were involved in the design of this study. 
 
Results 
  
 
1. General trends in NHS funded elective and emergency hip arthroplasties 
between 1997/98 to 2012/13 (figure 1, table 1) 
 
Between 1997/8 and 2012/13 the number of NHS funded elective primary hip 
arthroplasties increased by 122% from 32,226 in 1997/98 to 71,492 in 2012/13, and 
emergency arthroplasties increased by 46% from 21,336 to 31,136. Over the same time 
period the age-standardised rate for elective hip arthroplasties increased from 77.3 
(95%CI 76.5 – 78.2) to 148.7 (95%CI 147.6-149.8) per 100,000 population and for 
emergency hip arthroplasties the rate increased from 54.4 (95%CI 53.7 – 55.1) in 
1997/98 to 65 (95%CI 64.2-65.7) per 100,000 population in 2012/13. 
 
2. Age-sex distribution of individuals undergoing NHS funded elective hip 
arthroplasties from 2004/05 to 2012/13 by provider type (figure 2, table 2) 
 
The age-sex distribution of those undergoing elective arthroplasties differed by 
provider. Overall, the proportions of younger males (0-59 years) and older females 
(over 75 years) were higher among NHS providers compared with private providers, 
25% versus 15% and 35% versus 23% respectively. 
 
 7 
3. Trends in NHS funded elective hip arthroplasties by provider type from 
2004/05 to 2012/13 (figure 3, table 3) 
 
The total number of NHS funded elective primary hip arthroplasties performed by the 
NHS and private providers increased by 44.6% between 2004/05 to 2012/13 from 
49,434 to 71,492. In 2004/05, 2% of NHS funded arthroplasties were performed by the 
private sector, this increased to 20% in 2012/13. 
 
Age-standardised NHS performed arthroplasty rates increased from 113.5 (112.5-
114.5) in 2004/05 to 130.0 (95%CI 129.0-131.1) arthroplasties per 100,000 population 
in 2007/08 before falling back to 118.8 (95%CI 117.8-119.7) arthroplasties per 100,000 
population in 2012/13. Age-standardised privately performed arthroplasty rates 
increased significantly year on year from 2.5 (95%CI 2.3-2.6) in 2004/05 to 29.9 (95%CI 
29.4-30.4) per 100,000 population in 2012/13. 
 
4. Trends in NHS funded elective hip arthroplasties by IMD quintile from 2004/05 
to 2012/13 (figure 4, table 4) 
 
Overall trends (figure 4 panel 1) 
The age-standardised rate of all NHS funded elective primary hip arthroplasties 
increased from 2004/05 to 2012/13 in all IMD quintiles (figure 3, panel 1) with the 
largest (40%) increase occurring in the least deprived quintile (IMD 5), 115.8 (95%CI 
113.6-118) to 162.5 (95%CI 160-164.9) arthroplasties per 100,000 population between 
2004/5 to 2012/13. The smallest increases occurred in IMD 2, 3 and 4, which increased 
by 22%, 22% and 25% respectively during the same time period. The treatment rate in 
the most deprived quintile (IMD 1) increased significantly by 37% from 111.3 (95%CI 
108.9-113.7) in 2004/05 to 152.2 (95%CI 149.4-154.9) arthroplasties per 100,000 
population in 2012/13.  
Age-standardised rates were significantly higher in IMD 4 compared to IMD 1, 2, 3 and 5 
for all years except 2012/13, when adjusted rates for both IMD 4 and 5 were similar 
164.6 (95%CI 162.1-167) and 162.5 (95% CI 160-164.9) and both significantly higher 
than IMD 1, 2 and 3.  
IMD 3 had significantly lower adjusted rates of arthroplasties compared to all other 
quintiles for all years except 2006/07, when IMD 1, 2 and 3 were all similar, and 
significantly lower than IMD 4 and 5.  
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NHS provided arthroplasty trends (figure 4, panel 2) 
There was no significant change in standardised rates for NHS provided arthroplasties 
from 2004/05 to 2012/13 in IMD2, 3 or 4.  
IMD 1 rates increased significantly from 103.7 (95%CI 101.5-106) arthroplasties per 
100,000 population in 2004/05 to 124.5 (95%CI 122.1-127.0) in 2007/08 before falling 
significantly to 119.0 (116.6 to 121.4) in 2012/13.  
IMD 5 rates increased significantly from 107.7 (95%CI 105.6-109.8) in 2004/05 to 
128.7 (95%CI 126.5-131) in 2007/08 before falling significantly to 118.2 (116.2 to 
120.2) in 2012/13.  
The lowest rates were in patients in IMD 3, where from 2007/08 arthroplasty rates 
were significantly lower than any other quintile.  
Arthroplasties rates were significantly higher in IMD 4 than all the other quintiles except 
from 2010/11, when rates were similar to IMD 1 and 5.  
 
Privately provided arthroplasty trends (figure 4, panel 3) 
Age-standardised privately provided elective primary hip arthroplasty rates increased 
significantly for all IMD quintiles with rates increasing in the least deprived quintile 
from 2.2 (95%CI 1.9-2.5) in 2004/05 to 35.4 (95%CI 34.3-36.5) arthroplasties per 
100,000 population in 2012/13. 
The highest rates year on year occurred in IMD 4 and IMD 5, significantly higher than 
the more deprived quintiles (IMD 1, 2 and 3).  
In 2004/05 there was no significant difference in adjusted treatment rates between IMD 
1 (2.1 per 100,000; 95%CI 1.8-2.5) and IMD 5 (2.2 per 100,000; 95%CI 1.9-2.5); this 
widened yearly and by 2012/13 the rate for IMD 5 (35.4 per 100,000; 95%CI 34.3-36.5) 
was significantly higher than that for IMD 1 (25.2 per 100,000; 95%CI 24.1-26.4).  
 
 
5. Trends in inequality in hip arthroplasty rates between 2004/05 to 2012/13 
(figure 5, table 5) 
 
Trends gradients were positive for all measures of inequality (except relative 
difference), suggesting a widening of inequalities over time; however none were 
statistically significant (p>0.05) in any measure of inequality (absolute, relative 
difference and slope and relative slope of index inequality).  
 
Discussion 
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Main findings  
 
From 1997/98 to 2003/04 there was a 50% increase in numbers and rates of NHS 
funded elective hip arthroplasties, delivered by NHS providers. From 2003/04 rates and 
numbers of NHS funded elective hip arthroplasties continued to increase being 
delivered by both increasing NHS and private provision. From 2007/08 overall 
provision continued to increase, but was driven by increasing private sector provision 
as NHS provision decreased. The most affluent groups benefitted the greatest from 
increasing private provision, however we found no statistically significant widening in 
inequalities in overall NHS funded hip arthroplasties between 2004/05 to 2012/13. This 
was due to the protective and buffering effects of NHS provision which still remained 
the predominant provider of elective hip arthroplasties during the study period.  
Our findings are similar to the findings of a Scottish study where increasing private 
sector provision was associated with a fall in NHS provision.(19) Since 2015 the Scottish 
government policy has been to ‘effectively eliminate use of the private sector for 
planned care’,(24) in England the Department of Health continues to adopt policies of 
outsourcing of health care provision.(25)  
 
Strengths and limitations of study 
 
This is the first study in England examining the effects of NHS funding of private 
provision on NHS direct provision and inequalities in access, using treatment rates by 
provider type.       
Limitations include lack of adjustment for need which is highest among more deprived 
groups,(16) thus differences observed between socio-economic groups will 
underestimate true inequities in treatment provision.  
Secondly, the extent to which privately funded patients are receiving hip arthroplasty is 
unknown as HES data does not capture data on privately funded and performed hip 
arthroplasties; it is difficult to estimate the impact on inequalities. Derived estimates 
from private providers who perform only privately funded hip arthroplasties suggest 
the number of privately funded hip arthroplasties fell by 25.5%, between 2004/05 and 
2010/11.(26) This contrasts with the rising trends in numbers of NHS funded hip 
arthroplasties performed.  Rates of private insurance have remained relatively static in 
the UK.  
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There is evidence that individuals who would have undergone privately funded hip 
arthroplasty transferred to NHS funding, as waiting times reduced.(26)  
Despite this substitution between private and NHS-funded joint replacements, we still 
found rates of NHS funded hip arthroplasties were consistently highest among the 2nd 
most affluent quintile.  The size of any substitution effect on inequality is difficult to 
quantify. Research by Mindell et at, found private funded coronary intervention was 
inversely related to need and exacerbated inequalities.(27)  
Thirdly, we were not able to examine where in the care pathway inequity occurs; GPs 
may be less likely to refer older, ethnic minorities and less educated patients; or 
geographic location of private providers combined with risk selection may result in 
some individuals being less likely to be treated by private providers.(2, 4, 28-31) We 
found private providers favoured less extremes of ages compared to NHS providers. 
Those individuals under 59 years for males and over 75 years of age for females 
requiring elective hip arthroplasty may represent more complex arthroplasties or 
associated comorbidities that are excluded by private providers. 
 
Implication of findings 
 
The large and sustained increases in NHS funded elective hip arthroplasties between 
1997/98 to 2007/08 was delivered using NHS providers. This period coincides with 
large increases in NHS funding, from £59 billion in 1997/98 to £110 billion in 2007/08 
(at 2010/11 prices) (32) demonstrating the NHS ability to increase capacity when 
supported by sufficient funding. 
Previous analysis by Cooper et al found no substantial widening of inequalities in 
waiting times by socioeconomic group during this period.(18) This is likely due to 
outsourcing still being in its infancy, contributing to less that 5% of NHS funded elective 
arthroplasties and large increases in NHS funding and provision.  
 
In 2017, 1 in 3 of all NHS funded elective hip arthroplasties are performed in the private 
sector.(14) If the trends shown here continue, where by private provision substitutes 
for NHS direct provision with risk selection favouring less deprived patients then 
widening inequalities are likely.  
 
The Health and Social Care Act 2012 places a duty on CCGs to ‘reduce inequalities 
between patients with respect to their ability to access health services’. Our findings 
suggest CCGs should immediately reassess private sector contracting, undertake further 
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research on its impact from 2012/13 onwards on inequalities and consider and monitor 
the impact both on direct NHS provision and inequalities.  
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Table 1 Crude and adjusted rates of NHS funded elective and emergency arthroplasties in England between 1997-98 to 2012-13 
 
Financial 
Year 
Population 
(England) 
No of 
arthroplasties  
Elective arthroplasties per 100,000 
population 
Emergency arthroplasties per 100,000 
population 
Crude rate Adjusted rate* Crude rate Adjusted rate* 
1997-98 48,664,777 53,983 66.2 77.3 (76.5-78.2) 43.4 54.4 (53.7-55.1) 
1998-99 48,820,583 60,027 74.4 86.9 (86-87.8) 47.6 59.4 (58.6-60.1) 
1999-00 49,032,872 61,423 75.2 88 (87.1-88.9) 49 61 (60.3-61.8) 
2000-01 49,233,311 62,613 78.3 91.7 (90.8-92.6) 47.9 59.1 (58.3-59.8) 
2001-02 49,449,746 64,443 81.1 95 (94-95.9) 48.2 58.7 (57.9-59.4) 
2002-03 49,679,267 70,002 89.7 104.9 (104-105.9) 50.3 61.1 (60.3-61.8) 
2003-04 49,925,517 75,122 99 115.5 (114.5-116.5) 50.7 61.6 (60.9-62.4) 
2004-05 50,194,600 76,152 100.1 116.4 (115.4-117.4) 50.9 61.7 (60.9-62.4) 
2005-06 50,606,034 78,405 102.7 119.3 (118.3-120.3) 51.5 61.9 (61.1-62.6) 
2006-07 50,965,186 83,121 110 127.8 (126.8-128.9) 52.3 62 (61.3-62.8) 
2007-08 51,381,093 91,066 121.8 140.5 (139.4-141.6) 54.5 63.8 (63.1-64.6) 
2008-09 51,815,853 93,873 124.7 142.8 (141.7-143.9) 55.1 64.1 (63.4-64.9) 
2009-10 52,196,381 94,017 122.9 139.8 (138.7-140.9) 56.5 65.2 (64.4-65.9) 
2010-11 52,642,452 98,824 129.8 146.6 (145.5-147.7) 57.1 65.3 (64.5-66) 
2011-12 53,107,169 102,302 133.5 150.2 (149.1-151.3) 58.5 66.1 (65.4-66.9) 
2012-13 53,493,729 102,939 133.5 148.7 (147.6-149.8) 58.2 65 (64.2-65.7) 
* Adjusted rates standardised by age and population to 2013 European standard population 
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Table 2 Age-sex distribution of individuals undergoing NHS funded elective hip arthroplasties from 2004/05 to 2012/13 by provider type 
 
 
 
NHS performed  Privately performed 
Age band Male Female Overall Male Female Overall 
0-59 25% 18% 21% 15% 20% 17% 
60-64 years 14% 12% 13% 14% 17% 15% 
65-69 years 17% 16% 17% 19% 20% 20% 
70-74 years 18% 18% 18% 21% 20% 20% 
75-79 years 14% 17% 16% 17% 15% 16% 
80-84 years 8% 12% 10% 10% 6% 9% 
Over 85 3% 6% 5% 4% 2% 3% 
 100% 100% 100% 100% 100% 100% 
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Table 3 Number, crude and adjusted rates of NHS funded elective arthroplasties in England by provider type between 2003-04 to 2012-13 
 
Financial 
Year 
Population 
(England) 
NHS provided elective arthroplasties  
Private provided elective 
arthroplasties  
No. of 
arthroplasties 
(% of total 
performed) 
CR AR (95% CI) 
No. of 
arthroplasties 
(% of total 
performed) 
CR AR (95% CI) 
2003-04 49,925,517 
49,016 
(100%) 
98.2 114.5 (113.5-115.6) 0 (0%) - - 
2004-05 50,194,600 49,029 (98%) 97.6 113.5 (112.5-114.5) 1,050 (2%) 2.1 2.5 (2.3-2.6) 
2005-06 50,606,034 50,647 (98%) 100.1 116.1 (115.1-117.1) 1,231 (2%) 2.4 2.9 (2.7-3.1) 
2006-07 50,965,186 53,761 (96%) 105.5 122.4 (121.4-123.5) 2,275 (4%) 4.5 5.3 (5.1-5.5) 
2007-08 51,381,093 58,062 (93%) 112.9 130 (129-131.1) 4,578 (7%) 8.9 10.4 (10.1-10.7) 
2008-09 51,815,853 57,651 (89%) 111.1 127.1 (126-128.1) 7,056 (11%)   13.6 15.7 (15.4-16.1) 
2009-10 52,196,381 56,377 (88%) 107.9 122.6 (121.5-123.6) 7,847(12%) 15 17.2 (16.9-17.6) 
2010-11 52,642,452 56,397 (82%) 107 120.7 (119.7-121.7) 12,011 (18%) 22.8 25.9 (25.5-26.4) 
2011-12 53,107,169 57,645 (81%) 108.4 121.8 (120.8-122.8) 13,329 (19%) 25.1 28.4 (28-28.9) 
2012-13 53,493,729 57,166 (80%) 106.7 118.8 (117.8-119.7) 14,326 (20%) 26.8 29.9 (29.4-30.4) 
CR = Crude Rate 
AR = Adjusted Rates standardised by age and population to 2013 European standard population 
95% CI = 95% Confidence Interval 
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Table 4 Crude and adjusted rates of NHS funded elective arthroplasties in England by deprivation quintile and provider type between 2003-04 to 2012-13 per 100,000 population 
 
Year 
Provider 
type 
IMD 1 
(20% most deprived) IMD 2 IMD 3 IMD 4 
IMD 5 
(20% least deprived) 
CR AR (95% CI) CR AR (95% CI) CR AR (95% CI) CR AR (95% CI) CR AR (95% CI) 
2004
-05 
All 90.1 111.3 (108.9-113.7) 97.3 112.2 (109.8-114.5) 100.1 105.9 (103.7-108) 126.2 131.6 (129.2-134) 110.3 115.8 (113.6-118) 
NHS 88.3 103.7 (101.5-106) 94.8 104 (101.8-106.2) 98.1 98.7 (96.7-100.7) 123.5 122.3 (120-124.5) 108.1 107.7 (105.6-109.8) 
Private 1.8 2.1 (1.8-2.5) 2.4 2.8 (2.4-3.1) 2 2 (1.7-2.3) 2.7 2.6 (2.3-3) 2.2 2.2 (1.9-2.5) 
2005
-06 
All 92.1 115.6 (113.2-118.1) 97.8 113.9 (111.5-116.2) 102.1 108 (105.8-110.1) 129.9 134.6 (132.2-136.9) 118.4 123.1 (120.8-125.4) 
NHS 89.9 107.1 (104.8-109.4) 95.6 105.9 (103.7-108.1) 99.6 100.2 (98.2-102.2) 126.5 124.4 (122.2-126.6) 115.7 114.3 (112.1-116.4) 
Private 2.2 2.6 (2.3-3) 2.2 2.5 (2.1-2.8) 2.5 2.5 (2.2-2.8) 3.5 3.4 (3-3.8) 2.6 2.6 (2.3-2.9) 
2006
-07 
All 93.6 119.2 (116.7-121.7) 103.2 120.9 (118.5-123.3) 110.5 116.8 (114.6-119.1) 140.1 144.6 (142.1-147) 131.3 135.5 (133.1-137.8) 
NHS 90.2 108.7 (106.4-111) 100.5 112 (109.7-114.2) 106.1 106.7 (104.6-108.7) 133.5 130.6 (128.4-132.9) 125.3 122.4 (120.2-124.6) 
Private 3.4 4.2 (3.7-4.6) 2.7 3.1 (2.7-3.5) 4.4 4.5 (4.1-4.9) 6.6 6.5 (6-7) 6 5.9 (5.4-6.4) 
2007
-08 
All 109.7 140.6 (137.9-143.3) 114.5 134.4 (131.9-136.9) 119 125.3 (123-127.6) 150.7 153.9 (151.4-156.5) 144.9 147.2 (144.7-149.7) 
NHS 102.6 124.5 (122.1-127) 106.3 118.2 (115.9-120.5) 110.6 110.7 (108.6-112.8) 139 134.7 (132.4-137) 133.6 128.7 (126.5-131) 
Private 7.1 8.8 (8.1-9.4) 8.3 9.4 (8.7-10) 8.4 8.5 (7.9-9) 11.7 11.2 (10.6-11.9) 11.2 10.8 (10.2-11.5) 
2008
-09 
All 110.9 143 (140.3-145.7) 113.8 133.9 (131.4-136.4) 121.5 127 (124.8-129.3) 157.1 158.4 (155.9-160.9) 150.4 150.7 (148.2-153.1) 
NHS 99.9 121.9 (119.5-124.4) 102.2 113.8 (111.6-116.1) 108.6 107.8 (105.7-109.8) 138.5 132.4 (130.1-134.6) 133.2 126.2 (124-128.3) 
Private 11 13.7 (12.9-14.5) 11.6 13.2 (12.4-14) 12.9 12.9 (12.1-13.6) 18.6 17.7 (16.9-18.5) 17.2 16.3 (15.5-17.1) 
2009
-10 
All 107.7 139.9 (137.2-142.5) 111 130.4 (127.9-132.8) 116.7 121.3 (119.1-123.5) 158.6 158.2 (155.7-160.7) 151.6 149.2 (146.8-151.6) 
NHS 96.4 118.5 (116.1-120.9) 99.3 110.2 (108.1-112.4) 103.5 102.1 (100.1-104.1) 136.4 128.7 (126.5-130.9) 130.5 121.7 (119.6-123.9) 
Private 11.2 14 (13.2-14.9) 11.8 13.2 (12.5-14) 13.2 13 (12.3-13.7) 22.2 20.9 (20-21.8) 21.1 19.5 (18.6-20.3) 
2010
-11 
All 112.1 146.5 (143.7-149.2) 115.5 136.1 (133.6-138.6) 125.7 129.8 (127.5-132.1) 168.5 166.2 (163.6-168.7) 160.7 155.7 (153.3-158.2) 
NHS 94.7 116.9 (114.5-119.3) 98.2 109.4 (107.3-111.6) 105 102.9 (100.9-104.9) 135.6 126.8 (124.7-129) 128.1 117.5 (115.5-119.6) 
Private 17.5 21.9 (20.9-23) 17.4 19.6 (18.7-20.6) 20.7 20.3 (19.4-21.2) 32.9 30.6 (29.6-31.7) 32.6 29.7 (28.7-30.8) 
2011
-12 
All 116.2 152.9 (150.1-155.7) 120.4 142.1 (139.6-144.6) 128.8 132.5 (130.2-134.8) 170.1 166.2 (163.7-168.7) 166.1 158.9 (156.5-161.4) 
NHS 97.6 121.4 (118.9-123.8) 100.4 112.1 (109.9-114.2) 105.9 103.5 (101.5-105.4) 134.4 124.5 (122.4-126.6) 129.9 117.8 (115.7-119.8) 
 20 
Private 18.5 23.6 (22.5-24.7) 19.9 22.6 (21.6-23.6) 22.8 22.3 (21.4-23.2) 35.6 33 (31.9-34.1) 36.2 32.6 (31.5-33.7) 
2012
-13 
All 115.8 152.2 (149.4-154.9) 116.8 137 (134.6-139.5) 126.6 129 (126.7-131.2) 171 164.6 (162.1-167) 172.8 162.5 (160-164.9) 
NHS 95.8 119 (116.6-121.4) 96.7 107.5 (105.4-109.6) 102.7 99.5 (97.6-101.4) 132.4 120.9 (118.9-123) 132.9 118.2 (116.2-120.2) 
Private 20.1 25.2 (24.1-26.4) 20.1 22.5 (21.5-23.5) 23.9 23.1 (22.1-24) 38.6 35.1 (34-36.2) 39.9 35.4 (34.3-36.5) 
CR = Crude Rate 
AR = Adjusted Rates standardised by age and population to 2013 European standard population 
95% CI = 95% Confidence Interval 
 
 
Table 5 – Indices of inequalities  
 
Measure of inequality: 2004 2005 2006 2007 2008 2009 2010 2011 2012 
Absolute difference in age standardised 
arthroplasty rates IMD 5 vs IMD 1 4.5 7.5 16.3 6.6 7.7 9.3 9.2 6 10.3 
Relative difference in age standardised arthroplasty 
rates IMD 5 vs IMD 1 0.040 0.065 0.137 0.047 0.054 0.066 0.063 0.039 0.068 
Slope of index inequality* 
14.2  
(18.1-10.2) 
17.8 
(21.7-13.8) 
28.1  
(31.9-24.2) 
16.2 
(11.9-20.4) 
19.7 
(24.2-15.3) 
22.9 
(27.8-18.1) 
24.0  
(28.8-19.2) 
17.7 
(22.4-13.0) 
23.5  
(28.5-18.5) 
Relative slope of index inequality 0.12 0.15 0.23 0.12 0.16 0.19 0.20 0.15 0.20 
* 95% Confidence interval 
